FDA grants breakthrough status to AI-based gastric cancer diagnostic

FDA granted breakthrough device designation to AI Medical Service's technology for diagnosing gastric cancer, the company said Monday.

The technology uses artificial intelligence to analyze endoscopy images for signs of gastric cancer, a hard-to-diagnose disease associated with a high rate of false negatives.